Dr Hong He
Senior Research Fellow
Department of Surgery
79 Scholarly works
3 Projects
HIGHLIGHTS
2026
Journal article
Knockout of PAK1 and PAK4 supresses tumour growth associated with vasculogenic mimicry inhibition through EphA2–VE-cadherin–MCAM pathway
DOI: 10.1186/s12964-026-02778-32026
Journal article
A Streamlined Protocol for Developing a Clinicopathological Prediction Model for Patient Survival of Post-Resection of Pancreatic Cancer
DOI: 10.1002/cam4.715352025
Journal article
The Effects of PAK-Regulated Tumour Vasculature on Gemcitabine Response of Pancreatic Cancer
DOI: 10.3390/cancers172134342025
Journal article
Knockout of p21-Activated Kinase 4 Stimulates MHC I Expression of Pancreatic Cancer Cells via an Autophagy-Independent Pathway
DOI: 10.3390/cancers170305112025
Journal article
P-21 Kinase 1 or 4 Knockout Stimulated Anti-Tumour Immunity Against Pancreatic Cancer by Enhancing Vascular Normalisation
DOI: 10.3390/ijms261783572025
Journal article
Evaluation of Nanoparticle-Based Plasma Enrichment on Individuals with Primary and Metastatic Pancreatic Cancer
DOI: 10.3390/cancers172337652022
Research grants (other domestic)
The Role of P21 Activated Kinase 4 (PAK4) in Pancreatic Cancer Tumorigenesis
RECENT SCHOLARLY WORKS
2025
Journal article
Targeting PAK1 or PAK4 Uncovers Different Mechanisms of Vascular Reprogramming in Pancreatic Cancer
DOI: 10.3390/cells142218062024
Journal article
A Tumor Homing Peptide-Linked Arsenic Compound Inhibits Pancreatic Cancer Growth and Enhances the Inhibitory Effect of Gemcitabine
DOI: 10.3390/ijms2521113662024
Journal article
PAK1 inhibition increases TRIM21-induced PD-L1 degradation and enhances responses to anti-PD-1 therapy in pancreatic cancer
DOI: 10.1016/j.bbadis.2024.1672362024
Journal article
Inhibition of P21-activated kinases 1 and 4 synergistically suppresses the growth of pancreatic cancer by stimulating anti-tumour immunity
DOI: 10.1186/s12964-024-01670-2
RECENT PROJECTS
2014
Research Grant
Effects of Two Chemical Reagents on Colorectal Cancer
2008
Research Grant
Identification of a New Target for Colon Cancer Therapy